CUV 0.00% $14.86 clinuvel pharmaceuticals limited

Revenue EXPLOSION Coming?, page-2

  1. 387 Posts.
    lightbulb Created with Sketch. 75
    Indeed, CUV's plan, although we sometimes bemoan and complain, does seem to be coming together very nicely in terms of revenue and profit. I REALLY want to buy more with the potential for the latest indications, but until I hear what the EMA say about the sixth indication, I'm actually afraid that, should it be negative, the historical shorting and manipulation could easily bring the SP to below $20 again. Having said that, with the historical safety data that CUV have produced upon which Scenesse has been approved as you say, I can't really see that they would spend time, effort and money on the sixth indication if they didn't believe that it would actually be efficacious to some degree.

    In anticipation of a fruitful meeting with the EMA..........

    GLA
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.86
Change
0.000(0.00%)
Mkt cap ! $744.5M
Open High Low Value Volume
$14.93 $15.07 $14.76 $684.2K 45.80K

Buyers (Bids)

No. Vol. Price($)
1 550 $14.86
 

Sellers (Offers)

Price($) Vol. No.
$14.99 219 1
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
$14.95
  Change
0.000 ( 0.36 %)
Open High Low Volume
$14.96 $15.07 $14.77 2565
Last updated 15.59pm 03/05/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.